Price of Soliris Far Too High, as Efgartigimod’s Likely Will Be: ICER
The Institute for Clinical and Economic Review (ICER), an independent nonprofit that evaluates the prices and benefits of medications in…
Articles by Marisa Wexler, MS
Efgartigimod Better Than Placebo at Easing gMG Symptoms: ADAPT Trial
More adults with generalized myasthenia gravis (gMG) who were treated with efgartigimod in a Phase 3 trial experienced minimal…
Robot-assisted Thymectomy Helps Man Get Back Outdoors
Robot-assisted thymectomy surgery — a procedure to remove the thymus gland, here done using a robotic system console —…
1st Patient Dosed in Phase 3 Trial of Batoclimab in China
The first participant has been dosed in a Phase 3 clinical trial testing the efficacy and safety of batoclimab (HBM9161)…
Swallowing Muscle Test May Help Diagnose MG
The flexible endoscopic evaluation of swallowing-tensilon test (FTT), a new diagnostic tool for myasthenia gravis (MG), can be used…
CAR T-cell Therapy Descartes-08 Eased MG Symptoms
Treatment with Descartes-08, an investigational CAR T-cell therapy, markedly eased symptoms of myasthenia gravis (MG) in three patients participating…
Differences Seen in Composition of Gut Microbiome in MG Patients
Differences in gut bacteria composition in people with myasthenia gravis (MG) may be a promising avenue to explore in…
Calprotectin, Inflammatory Protein, May Be Biomarker of MG Severity
An inflammation-associated protein called calprotectin is present at abnormally high levels in the blood of people with myasthenia gravis…
MG Severity Linked With Female Sex, Obesity and Diagnostic Delay
Myasthenia gravis (MG) tends to be more severe in people who are female, obese, or who took a long…
Immunovant Will Use $200M Investment to Advance IMVT-1401
Immunovant will use a $200 million strategic investment from Roivant Sciences to advance IMVT-1401, its investigational therapy for…